Search

Nicholas Jon Virca

from Tampa, FL
Age ~78
Get Report
Also known as:
Nicholas J Virca, Nicholas Jon Vica, Nicholas J Birca, Nichols J Virca, Nicholas J Virea, Nicholas Virch
Phone and address:
449 S 12Th St UNIT 1705, Tampa, FL 33602
Related to:
David Accarino, 32Ida M Anton, 83Ana Accarino, 68Jennifer Accarino, 39Amanda Accarino, 36
Connected to:
Vanessa D Virchaux, 36Gurmit S Virdee, 69Lee S Virdell, 48Barclay G Virden, 53Benjamin A Virden, 46Chris D Virden, 39Dan H Virden, 75Dawn M Virden, 45Diane M Virden, 53Gail L Virden, 73

Nicholas Virca Phones & Addresses

  • 449 S 12Th St UNIT 1705, Tampa, FL 33602
  • Santee, CA
  • Foster City, CA
  • 11466 Winding Ridge Dr, San Diego, CA 92131
  • 700 Harbor Dr, San Diego, CA 92101
  • 700 W Harbor Dr #1104, San Diego, CA 92101
  • Franklin, MA
  • Lemon Grove, CA

Work

Company: Hedgepath pharmaceuticals Apr 2012 Address: San Diego, California - Tampa, Florida Position: President & ceo

Education

Degree: BACHELORS School / High School: Youngstown State University Specialities: BIOLOGY

Industries

Biotechnology

Resumes

Resumes

Nicholas Virca Photo 1

Ceo Hedgepath Pharmaceuticals

View page
Position:
President & CEO at HedgePath Pharmaceuticals, Inc., Partner at Hopkins Capital Group
Location:
San Diego, California
Industry:
Biotechnology
Work:
HedgePath Pharmaceuticals - San Diego, California - Tampa, Florida since Apr 2012
President & CEO
Hopkins Capital Group - Tampa, FL since Dec 2011
Partner
Entegris - Billerica, MA Apr 2013 - May 2013
Life Sciences Advisory Board
LamdaGen Corporation - Menlo Park, CA Mar 2008 - Dec 2011
COO
Interphex Advisory Board 2007 - Nov 2011
Board member
Education:
Youngstown State University
BACHELORS, BIOLOGY Youngstown State University
Bachelor's degree, Biological Sciences

Business Records

Name / Title
Company / Classification
Phones & Addresses
Nicholas Virca
President, Chief Executive Officer
Adventrx Pharmaceuticals, Inc
Commercial Physical Research
9948 Hibert St, San Diego, CA 92131
(858) 552-0241
Nicholas Virca
CEO, Chairman, President
HEDGEPATH PHARMACEUTICALS, INC
Commercial Physical Research · Commercial Physical Research, Nsk
324 S Hyde Park Ave SUITE 350, Tampa, FL 33606
Nicholas J. Virca
President
PERARDUA CORPORATION
11466 Winding Rdg Dr, San Diego, CA 92131

Publications

Us Patents

Azole Treatment Regimen With Reduced Hepatotoxicity

View page
US Patent:
20190365742, Dec 5, 2019
Filed:
May 30, 2019
Appl. No.:
16/425987
Inventors:
- TAMPA FL, US
NICHOLAS J. VIRCA - TAMPA FL, US
International Classification:
A61K 31/496
A61K 47/38
A61K 47/36
A61K 9/00
A61K 47/02
Abstract:
The present invention concerns methods for managing hepatotoxicity in a subject undergoing treatment with a composition comprising an azole inhibitor of the Hedgehog signaling pathway (azole inhibitor), such as itraconazole or an analogue thereof, comprising suspending, for a period of time, the administration of the composition to the subject exhibiting hepatotoxicity, and re-administering the composition to the subject with a reduced dosage of the azole inhibitor.

Hedgehog Pathway Inhibition For Treatment Of High-Risk Basal Cell Carcinoma Or High-Risk Basal Cell Carcinoma Nevus Syndrome

View page
US Patent:
20190365743, Dec 5, 2019
Filed:
May 30, 2019
Appl. No.:
16/425992
Inventors:
- TAMPA FL, US
NICHOLAS J. VIRCA - TAMPA FL, US
International Classification:
A61K 31/496
A61K 31/337
A61K 9/00
Abstract:
The present invention concerns methods for treating high-risk basal cell carcinoma (BCC) or high-risk basal cell carcinoma nevus syndrome (BCCNS) in a subject, comprising administering a composition comprising an azole inhibitor of the Hedgehog signaling pathway (azole inhibitor) to the subject.
Control profile
Nicholas Jon Virca from Tampa, FL, age ~78 Get Report